You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Enzyme Inhibitors

Showing 1 - 25 of 6,800
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Therapeutic Drug Use for CKD Patients

Active, not recruiting
  • Chronic Kidney Disease
  • angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
  • Jinan, Shandong, China
    Xiao Li，MD
Apr 18, 2023

Angiotensin Converting Enzyme Inhibitors and Angiotensin

Not yet recruiting
  • COVID-19 Pneumonia
  • Covid_19
  • (no location specified)
Jun 5, 2022

Bradykinin-degradating Enzymes Activities in

Recruiting
  • Angio-Oedema Caused by Angiotensin-Converting-Enzyme Inhibitor
  • Assay of Bradykinin-degradating enzymes.
  • Grenoble, France
    Chu Grenoble Alpes
Jan 14, 2022

Vascular Access Complication Trial in Rawalpindi (Losartan Potassium, multi-vitamins)

Recruiting
  • Vascular Access Complication
  • Rawalpindi, Punjab, Pakistan
    Anas Bin Saif
Nov 22, 2021

Surgery, Angiotensin Hypertension, Perioperative Complication Trial in Netherlands (drug, diagnostic test, behavioral)

Recruiting
  • Surgery
  • +2 more
  • Perioperative withdrawal of angiotensin converting enzyme inhibitors and angiotenin receptor blockers
  • +4 more
  • Amsterdam, Netherlands
  • +6 more
Jan 6, 2022

AML, Acute Myeloid Leukemia Trial in Charlottesville (Cardioprotection)

Recruiting
  • AML
  • Acute Myeloid Leukemia
  • Charlottesville, Virginia
    University of Virginia
Jul 2, 2022

Chronic Kidney Disease, Blood Pressure, Angiotensin-converting Enzyme Inhibitor Trial in San Francisco (Continuation of ACEi

Active, not recruiting
  • Chronic Kidney Disease
  • +3 more
  • Continuation of ACEi and/or ARBs
  • San Francisco, California
    University of California, San Francisco
Oct 4, 2021

Male Erectile Disorder, Prostate Cancer, Radiation Toxicity Trial in Winston-Salem (Placebo, Oral L-Arginine)

Completed
Has Results
  • Male Erectile Disorder
  • +2 more
  • Placebo
  • Oral L-Arginine
  • Winston-Salem, North Carolina
    W F Baptist Health
Sep 7, 2021

STEMI - ST Elevation Myocardial Infarction, Left Ventricular Systolic Dysfunction Trial (Dapagliflozin 10Mg Tab, Placebo)

Not yet recruiting
  • STEMI - ST Elevation Myocardial Infarction
  • Left Ventricular Systolic Dysfunction
  • Dapagliflozin 10Mg Tab
  • Placebo
  • (no location specified)
Sep 6, 2021

Angiotensin Converting Enzyme Inhibitors and Incident

Unknown status
  • Covid-19, Coronavirus, Angiotensin Converting Enzyme Inhibitors, Influenza, Electronic Health Records, Epidemiology, Comorbidity, Incidence, United Kingdom
  • ACE inhibitor
  • (no location specified)
Nov 11, 2020

Cutaneous Melanoma Trial in Paris (Blood sample, Cutaneous melanoma biopsy)

Recruiting
  • Cutaneous Melanoma
  • Blood sample
  • Cutaneous melanoma biopsy
  • Paris, Ile De France, France
    Dermatology department
Oct 24, 2022

Chagas Cardiomyopathy Trial in São Paulo (Sacubitril / Valsartan Oral Tablet [Entresto], Enalapril)

Recruiting
  • Chagas Cardiomyopathy
  • Sacubitril / Valsartan Oral Tablet [Entresto]
  • Enalapril
  • São Paulo, Brazil
    Heart Institute (Incor) University of Sao Paulo
May 6, 2021

NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in Worldwide (Furmonertinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • +14 more
  • Glendale, California
  • +12 more
Feb 2, 2023

Exercise, Angiotensin-Converting Enzyme Inhibitors Trial in Copenhagen (Enalapril, Placebo)

Completed
  • Exercise
  • Angiotensin-Converting Enzyme Inhibitors
  • Copenhagen, Denmark
    Department of Nutrition, Exercise and Sports
Nov 3, 2020

Transcatheter Aortic Valve Replacemen, Angiotensin-Converting Enzyme Inhibitors Trial in Valladolid (Ramipril)

Active, not recruiting
  • Transcatheter Aortic Valve Replacemen
  • Angiotensin-Converting Enzyme Inhibitors
  • Valladolid, Spain
    Hospital Clínico Universitario de Valladolid
Sep 23, 2021

Hematoma, Subdural, Chronic Trial (Perindopril, Placebo)

Terminated
Has Results
  • Hematoma, Subdural, Chronic
  • (no location specified)
Aug 18, 2020

Human Immunodeficiency Virus Type 1 (HIV-1) Infection Trial (Vesatolimod, Cobicistat, Voriconazole)

Not yet recruiting
  • Human Immunodeficiency Virus Type 1 (HIV-1) Infection
  • (no location specified)
Jul 11, 2022

Hypertension, COVID-19 Trial in Kiev (Angiotensin converting enzyme inhibitor, Angiotensin Receptor Blockers, Direct renin

Completed
Has Results
  • Hypertension
  • COVID-19
  • Angiotensin converting enzyme inhibitor
  • +2 more
  • Kiev, Please Select, Ukraine
    Medical Practice Prof D.Ivanov
Feb 16, 2022

Pathophysiologic Hemodynamics After Primary Unilateral Total Hip

Recruiting
  • Orthostatic Intolerance
  • Orthostatic Hypotension
  • Mobilisation procedure
  • Copenhagen, Denmark
    Hvidovre University Hospital
Apr 8, 2021

Hydroxychloroquine, Antimalarials, Enzyme Inhibitors Trial in Mexico City (Hydroxychloroquine Sulfate, Bromhexine 8 MG)

Enrolling by invitation
  • Hydroxychloroquine
  • +3 more
  • Hydroxychloroquine Sulfate
  • Bromhexine 8 MG
  • Mexico City, Cdmx, Mexico
    National Institute of Rehabilitation, Luis Guillermo Ibarra Ibar
Jun 26, 2021

Kidney Disease Trial in United States (Bremelanotide, RAAS inhibition therapy)

Recruiting
  • Kidney Disease
  • Chula Vista, California
  • +5 more
Jan 23, 2023

Coronavirus Disease 2019 Patients Receiving Receiving

Completed
  • COVID-19
  • Angiotensin-Converting Enzyme Inhibitors (ACE-I) and Angiotensin II Receptor Blockers (ARB)
  • Riyadh, Saudi Arabia
    King Faisal Specialist Hospital & Research Centre
Aug 1, 2020

Diabetes, Cardiovascular Diseases Trial in Singapore (Renin-angiotensin-aldosterone system inhibitors, Beta blocker, SGLT2

Recruiting
  • Diabetes Mellitus
  • Cardiovascular Diseases
  • Renin-angiotensin-aldosterone system inhibitors
  • +2 more
  • Singapore, Singapore
    Singapore General Hospital (SGH)
Apr 28, 2021

COVID-19, Cardiovascular Diseases Trial in Brazil, Canada, Mexico (Angiotensin converting enzyme inhibitor, Angiotensin II

Recruiting
  • COVID-19
  • Cardiovascular Diseases
  • Angiotensin converting enzyme inhibitor
  • Angiotensin II Receptor Blockers
  • Maceio, Alagoas, Brazil
  • +30 more
Jan 13, 2023

NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in United States (furmonertinib 240 mg, furmonertinib 160 mg, platinum-based chemo)

Recruiting
  • Non-Small Cell Lung Cancer
  • +13 more
  • furmonertinib 240 mg
  • +2 more
  • Yuma, Arizona
  • +37 more
Dec 14, 2022